Investment analysis, share recommendations, and market insights.
Here are three stocks poised to smash through the $20 level in share price – in the cases of Orica and Northern Star, heading back above $20.
Some overseas royalty companies have been excellent investments and look like a good bet in volatile markets. Although having a low market profile, they can be attractive long-term investments. Here are two royalty plays that could be sources of income for long-term investors.
In our “HOT” stock article today, Michael Gable, Managing Director of Fairmont Equities, says he sees bullish signs for BHP.
Today I’m putting last Saturday’s star performing stocks under the analysts’ microscope to see if the gains are a sign of better returns to come. Three out of four of these look very interesting.
Last week, three of the major banks reported full year profit results (CBA will provide a third quarter trading update on Wednesday). Here’s a review of what we learnt and my position in relation to the question about how to play the banks going forward.
“Macquarie (MQG) financial year 2025 net profit after tax (NPAT) of $3.7 billion was +1% above Factset consensus (A$3.7 billion),” Raymond said. “Overall, we saw […]
Here are two micro-cap companies that ply their trade in industries where both regulation and the search for economic efficiency is pushing participants toward the solutions they offer. Patient investors could be well-rewarded in the long run.
Here are two undervalued listed property trusts that own childcare centres.
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, explains why Regis Healthcare (REG) is currently a buying opportunity.
I’ve been looking for recommendations for two of my financial planning clients. I’ll share with you what I’ve come up with. Be clear on this: if they were full-on growth investors, then I’d be more aggressive.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.